Altered levels of the synaptosomal associated protein SNAP-25 in schizophrenia

@article{Thompson1998AlteredLO,
  title={Altered levels of the synaptosomal associated protein SNAP-25 in schizophrenia},
  author={Peter M. Thompson and A C Sower and Nora I. Perrone-Bizzozero},
  journal={Biological Psychiatry},
  year={1998},
  volume={43},
  pages={239-243}
}
BACKGROUND Identifying brain changes in schizophrenia has been a major research focus for many years. Although impressive gains have been made in neuroimaging and brain electrophysiology, molecular and cellular markers of schizophrenia have lagged. There are no consistent biochemical markers for schizophrenia pathophysiology and none that reflect treatment course. METHODS Samples were obtained from 25 postmortem schizophrenic brains and 31 nonschizophrenic controls. These samples were… Expand
Increased levels of SNAP-25 and synaptophysin in the dorsolateral prefrontal cortex in bipolar I disorder.
TLDR
Changes in SNAP-25 and synaptophysin in BPDI suggest that changes in specific neuronal functions could be linked to the pathology of the disorder. Expand
CSF levels of synaptosomal-associated protein 25 and synaptotagmin-1 in first-episode psychosis subjects
TLDR
Cerebrospinal fluid concentrations of the two pre-synaptic proteins synaptosomal-associated protein 25 (SNAP-25) and synaptotagmin-1 (SYT-1), both of which are increased in conditions of ongoing synaptic degeneration, were measured in 44 FEP subjects and 21 healthy controls using immunoprecipitation mass spectrometry. Expand
SNAP-25 reduction in the hippocampus of patients with schizophrenia
TLDR
The authors confirm the previous report of less SNAP-25 immunoreactivity in the hippocampus using a different cohort of patients with schizophrenia and indicate that the overall level of NMDA glutamatergic synapses in hippocampus is normal. Expand
Summary of Prefrontal Molecular Abnormalities in the Stanley Foundation Neuropathology Consortium
Postmortem specimens from the Stanley Foundation Neuropathology Consortium, which contains matched samples from patients with schizophrenia, bipolar disorder, non-psychotic depression, and normalExpand
Altered levels of the synaptosomal associated protein SNAP-25 in hippocampus of subjects with mood disorders and schizophrenia
TLDR
The reported changes in SNAP-25 levels appear to be disease specific, separating synaptic pathology in unipolar depression from that observed in schizophrenia and bipolar disorders. Expand
Elevated cerebrospinal fluid SNAP-25 in schizophrenia
TLDR
These observations confirm the previous report of elevated CSF SNAP-25 and suggest that synaptic pathology may be linked with the pathophysiology of schizophrenia. Expand
SNAP-25a/b Isoform Levels in Human Brain Dorsolateral Prefrontal Cortex and Anterior Cingulate Cortex
TLDR
Examination of SNAP-25 total and isoform levels in postmortem cortex Brodmann's area 9 and BA24 suggests that the protein levels may be useful biomarkers beyond limited neurological and psychiatric diagnostic categories. Expand
Relevance of Presynaptic Proteins to Neuropsychiatric Disorders
TLDR
These findings represent the first description significantly linking synaptic proteins to cognitive function in schizophrenia and provide evidence that SNAP-25 and complexins may be implicated in the pathophysiology of additional psychiatric and neurological disorders, as well as in the therapeutic efficacy of drugs used in the treatment of these disorders. Expand
Synaptophysin gene expression in schizophrenia
TLDR
Synaptophysin expression is decreased in some cortical areas in schizophrenia, and the alterations affect the mRNA more than the protein, and have an unexpected regional distribution. Expand
SNAP-25 a / b Isoform Levels in Human Brain Dorsolateral Prefrontal Cortex and Anterior Cingulate Cortex
SNAP-25 is a neurotransmitter vesicular docking protein which has been associated with brain disorders such as attention deficit hyperactivity disorder, bipolar disorder and schizophrenia. In thisExpand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 24 REFERENCES
Increased levels of GAP-43 protein in schizophrenic brain tissues demonstrated by a novel immunodetection method.
TLDR
The hypothesis that schizophrenia is associated with a perturbed organization of synaptic connections in associative areas of the human brain is supported by the results of this method. Expand
Significant reductions in synapsin but not synaptophysin specific activity in the brains of some schizophrenics
TLDR
Given that synapsin is thought to regulate neurotransmitter release, it is possible that this deficit insynapsin could result in abnormal processing of neuronal information as is seen in various sensory processing abnormalities associated with schizophrenia. Expand
Altered synaptophysin expression as a marker of synaptic pathology in schizophrenia
TLDR
The data support the broad hypothesis that synaptic pathology occurs in schizophrenia and suggest that pyramidal neurons within the medial temporal lobe may form fewer synapses, although the lack of any significant differences in synaptophysin immunoreactivity despite the loss of encoding messenger RNA means that this conclusion must be drawn cautiously. Expand
Decreased expression of the embryonic form of the neural cell adhesion molecule in schizophrenic brains.
TLDR
The decrease in PSA-NCAM immunoreactivity in schizophrenic hippocampi may suggest an altered plasticity of this structure in a large proportion of schizophrenic brains, and may bear significance to the "neurodevelopmental hypothesis" of schizophrenia. Expand
Abnormal expression of two microtubule-associated proteins (MAP2 and MAP5) in specific subfields of the hippocampal formation in schizophrenia.
TLDR
Defects in the expression of MAP2 and MAP5, two proteins that contribute to the establishment and maintenance of neuronal polarity, could underlie some of the cytoarchitectural abnormalities described in schizophrenia and impair signal transduction in the affected dendrites. Expand
Localization of the growth-associated phosphoprotein GAP-43 (B-50, F1) in the human cerebral cortex
TLDR
The pronounced variations in GAP-43 immunostaining among various areas of the human brain may reflect different potentials for functional and/or structural remodeling. Expand
Quantitative autoradiographic analysis of glutamate binding sites in the hippocampal formation in normal and schizophrenic brain post mortem
TLDR
The anatomical distribution of the binding sites for the excitatory neurotransmitter glutamate has been established in the hippocampal formation from control and schizophrenic brains, post mortem and represent novel targets for therapeutic manipulation in schizophrenia. Expand
Reduced temporal limbic structure volumes on magnetic resonance images in first episode schizophrenia
TLDR
The results demonstrate abnormal medial temporal lobe morphology in a subgroup of patients at the onset of their illness, which might explain some of the clinical features of the disease. Expand
Anatomical distribution of the growth-associated protein GAP-43/B-50 in the adult rat brain
TLDR
This distributional pattern raises the question of whether synapses in all areas containing high levels of GAP-43/B-50 are capable of undergoing functional plasticity, or whether the protein may function in some of these areas in some other capacity. Expand
Post-mortem volume measurements of limbic system and basal ganglia structures in chronic schizophrenics: Initial results from a new brain collection
TLDR
Volume differences in the schizophrenic group can not be explained by a general brain atrophy or hypoplasia but rather indicate a more focal lack of brain tissue, by which some clinical features of the disease might be explained. Expand
...
1
2
3
...